NMD Pharma
Entry
2022
Hold
4yr
Status
Active
Who owns NMD Pharma?
NMD Pharma is a French Biotech company, currently owned by Jeito Capital since 2022 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYOwnership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2016 · present
Novo HoldingsActive
2016 · present(10yr) · Novo Holdings Seed Investments · 1999 · VC
Jeito CapitalActive
2022 · present(4yr) · Jeito I · 2021 · VC
More from Jeito I
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns NMD Pharma?
NMD Pharma is currently owned by Jeito Capital, Novo Holdings and 1 other, through Jeito I, since 2022.
When did Jeito Capital and 2 others acquire NMD Pharma?
Jeito Capital and 2 others acquired NMD Pharma in 2022.
Who has owned NMD Pharma over time?
NMD Pharma has been through 3 private-equity ownership periods: Novo Holdings · via Novo Holdings Seed Investments · since 2016; Lundbeckfonden BioCapital · via Lundbeckfonden BioCapital · since 2016; Jeito Capital · via Jeito I · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue